Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 25 tags : Positive save search
Madrigal Pharmaceuticals Announces Presentation of Positive Clinical Data of Resmetirom from Open-Label Portion of Ongoing Phase 3 Clinical Trial MAESTRO-NAFLD-1 at The International Liver Congress™ 2021
Published: 2021-06-25 (Crawled : 16:00) - globenewswire.com
MDGL M | $228.46 -1.94% -1.98% 250K
|
Health Technology
|
| O: 0.63%
H: 1.02%
C: -0.96%
presentation ongoing positive phase 3 liver trial
Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
Published: 2021-06-25 (Crawled : 14:00) - globenewswire.com
FGEN | $1.265 -2.69% -2.77% 1M
|
Health Technology
|
| O: 2.75%
H: 0.79%
C: -7.43%
disease positive anemia chmp kidney
Nationally Recognized Environmental Firm Expands Partnership: Attracts Prominent Former Troutman, Pepper Partner and Elevates Two Lawyers to Partnership Positions.
Published: 2021-06-25 (Crawled : 13:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.63%
H: 0.0%
C: -5.18%
partnership positive
Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Receives Positive Opinion on Orphan Medicinal Product Designation by EMA
Published: 2021-06-25 (Crawled : 13:15) - globenewswire.com
YMAB | $15.09 -0.33% -0.33% 450K
|
Health Technology
|
| O: 0.35%
H: 2.4%
C: -0.69%
treatment positive ema designation
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 13:00) - biospace.com/
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 12:15) - biospace.com/
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Published: 2021-06-25 (Crawled : 12:00) - investors.biomarin.com
BMRN | News S | $90.48 -0.43% -0.43% 1.3M
|
Health Technology
|
| O: 0.66%
H: 1.39%
C: 0.55%
treatment europe drop positive children growth chmp achondroplasia
Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma (idecabtagene vicleucel) for Relapsed and Refractory Multiple Myeloma
Published: 2021-06-25 (Crawled : 12:00) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.12%
H: 1.76%
C: 1.23%
positive therapy chmp car-t t-cell
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy
Published: 2021-06-25 (Crawled : 12:00) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.12%
H: 1.76%
C: 1.23%
disease treatment positive therapy cancer iot chmp nivolumab
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Ranibizumab Biosimilar, BYOOVIZ™
Published: 2021-06-25 (Crawled : 12:00) - globenewswire.com
BIIB | $192.13 -1.55% -1.57% 1.3M
|
Health Technology
|
| O: -0.14%
H: 1.41%
C: -0.21%
positive chmp biosimilar
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.